A detailed history of Arizona State Retirement System transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 52,672 shares of RXRX stock, worth $368,177. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,672
Previous 47,691 10.44%
Holding current value
$368,177
Previous $357,000 2.8%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.92 - $8.6 $29,487 - $42,836
4,981 Added 10.44%
52,672 $347,000
Q2 2024

Aug 05, 2024

BUY
$7.35 - $10.05 $34,986 - $47,838
4,760 Added 11.09%
47,691 $357,000
Q1 2024

May 07, 2024

BUY
$9.13 - $15.52 $27,435 - $46,637
3,005 Added 7.53%
42,931 $428,000
Q4 2023

Jan 24, 2024

BUY
$5.09 - $10.79 $15,906 - $33,718
3,125 Added 8.49%
39,926 $393,000
Q3 2023

Nov 06, 2023

BUY
$6.59 - $15.86 $4,830 - $11,625
733 Added 2.03%
36,801 $281,000
Q2 2023

Aug 01, 2023

BUY
$4.56 - $9.94 $92,449 - $201,523
20,274 Added 128.37%
36,068 $269,000
Q1 2023

Apr 27, 2023

BUY
$6.42 - $9.64 $11,652 - $17,496
1,815 Added 12.98%
15,794 $105,000
Q4 2022

Feb 07, 2023

BUY
$7.16 - $12.7 $4,453 - $7,899
622 Added 4.66%
13,979 $107,000
Q3 2022

Nov 07, 2022

BUY
$7.83 - $13.6 $3,038 - $5,276
388 Added 2.99%
13,357 $142,000
Q2 2022

Jul 28, 2022

BUY
$5.04 - $9.26 $11,027 - $20,260
2,188 Added 20.29%
12,969 $106,000
Q1 2022

May 04, 2022

BUY
$6.16 - $18.03 $498 - $1,460
81 Added 0.76%
10,781 $77,000
Q4 2021

Feb 04, 2022

BUY
$16.14 - $21.86 $172,698 - $233,902
10,700 New
10,700 $183,000

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.26B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.